WHITEBOX ADVISORS LLC 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-25 4:23 pm Sale | 2024-09-30 | 13G | Protalix BioTherapeutics, Inc. PLX | WHITEBOX ADVISORS LLC | 0 0.000% | -2,816,108 (Position Closed) | Filing |
| 2022-06-09 2:52 pm Purchase | 2022-05-13 | 13G | Protalix BioTherapeutics, Inc. PLX | WHITEBOX ADVISORS LLC | 2,816,108 5.650% | 2,816,108 (New Position) | Filing |